Company/EPS Estimate
- (AMR)/.75
- (ABT)/.66
- (BLK)/1.90
- (CIT)/1.23
- (CMA)/1.22
- (KO)/.68
- (GCI)/1.00
- (MAN)/1.39
- (MTG)/.61
- (MI)/.83
- (PJC)/.50
- (UTX)/1.16
- (MO)/1.14
- (JPM)/.90
- (ITW)/.87
- (SYK)/.55
- (TER)/.18
- (ALL)/1.70
- (RX)/.40
- (KNX)/.19
- (NE)/1.17
- (WM)/.23
- (BOT)/1.18
- (GRB)/.10
- (KMP)/.42
Bristol-Myers Squibb Co. (BMY) rose 76 cents, or 2.6 percent, to $30 in extended trading yesterday. The company won U.S. approval for a drug to treat the most advanced form of breast cancer, a U.S. Food and Drug Administration spokeswoman said.
CSX Corp. (CSX) rose 97 cents, or 2.3 percent, to $43.80 in extended trading. The third-largest U.S. railroad said third- quarter profit increased to 91 cents a share. The company was expected to earn 62 cents, the average of analyst estimates.
Intel Corp. (INTC) rose $1.31, or 5.1 percent, to $26.79 in extended trading yesterday. The world's largest semiconductor maker said fourth-quarter sales may climb to $10.5 billion to $11.1 billion. Analysts predicted sales of $10.4 billion, according to the average of estimates.
Security Capital Assurance Ltd. (SCA) declined 97 cents, or 4.6 percent, to $19.90 in extended trading yesterday. The Hamilton, Bermuda-based financial insurer and reinsurer expects to report a third-quarter net loss because of a $145 million writedown on credit derivatives.
Watch NKE, APA, EXM, MOS for long breakouts.
-MM
